Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SKYE
Stock Latest News
The Fly
Largest borrow rate increases among liquid names
20d ago
SLI
VOR
Premium
Ratings
Buy Rating for Skye Bioscience: Nimacimab’s Potential in Enhancing Obesity Treatment Efficacy
20d ago
SKYE
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
21d ago
MU
VZ
Premium
The Fly
Skye Bioscience downgraded to Hold from Buy at Craig-Hallum
21d ago
SKYE
Premium
The Fly
Fifth Third buying Comerica, AMD gets OpenAI boost: Morning Buzz
21d ago
BA
CG
Premium
Ratings
Promising Phase IIa Results and Favorable Safety Profile Drive Buy Rating for Skye Bioscience’s Nimacimab
21d ago
SKYE
Premium
The Fly
Skye Bioscience downgraded to Neutral from Overweight at Cantor Fitzgerald
21d ago
SKYE
Premium
The Fly
Skye Bioscience downgraded to Neutral from Overweight at Cantor Fitzgerald
21d ago
SKYE
Premium
Company Announcements
Skye Bioscience Reveals Phase 2a Study Results
21d ago
8K
SKYE
Premium
Market News
Why Is Skye Bioscience Stock Down 60% Today?
21d ago
SKYE
Premium
The Fly
Skye Bioscience says nimacimab did not meet primary endpoint in CBeyond study
21d ago
SKYE
Premium
Ratings
Buy Rating for Skye Bioscience: Nimacimab’s Potential in Obesity Treatment Market
26d ago
SKYE
Premium
The Fly
Skye Bioscience initiated with a Buy at H.C. Wainwright
27d ago
SKYE
Premium
The Fly
Skye Bioscience presents Phase 1b data from nimacimab study
1M ago
SKYE
Premium
Ratings
Skye Bioscience’s Nimacimab: Promising Phase IIa Trial Results and Buy Recommendation
1M ago
SKYE
Premium
Ratings
Skye Bioscience’s Transformative Potential in Obesity Treatment: A Buy Recommendation by Andy Hsieh
2M ago
SKYE
Premium
The Fly
Skye Bioscience reports results from two preclinical DIO studies on nimacimab
2M ago
SKYE
Premium
The Fly
Skye Bioscience completes 26-week treatment phase in Phase 2a CBeyond study
2M ago
SKYE
Premium
The Fly
Skye Bioscience to host KOL event on CBeyond Phase 2a clinical data readout
2M ago
SKYE
Premium
The Fly
Evercore starts Skye Bioscience at Outperform on nimacimab potential
2M ago
SKYE
Premium
The Fly
Skye Bioscience initiated with an Outperform at Evercore ISI
2M ago
SKYE
Premium
Company Announcements
Skye Bioscience Earnings Call: Positive Outlook Amid Challenges
3M ago
SKYE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
